检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:李雯燕[1] 宋国平[1] 曹丽霞[1] 李光来[1] 赵文新[1] 周全[1] 邹玉琴[1] 何成斌[1] 赵振新[1] 周生潮[1]
机构地区:[1]新疆生产建设兵团十三师红星医院,新疆哈密839000
出 处:《风湿病与关节炎》2013年第7期12-14,18,共4页Rheumatism and Arthritis
基 金:兵团十二五预备科技公关项目(2012BA035)
摘 要:目的:观察中药经典方桂芍知母汤联合来氟米特治疗急性期类风湿关节炎的临床疗效。方法:将80例急性期类风湿关节炎患者按就诊时间顺序随机分为治疗组和对照组,每组40例。对照组给予来氟米特每日20mg治疗,治疗组在对照组的基础上加用桂芍知母汤治疗,两组根据病情需要应用非甾体类抗炎药(双氯芬酸钠双释放肠溶胶囊每日75mg)或小剂量激素每日7.5mg,不超过4周治疗。两组疗程均为12周。对两组患者6周、12周临床疗效相关指标进行比较。结果:在各观察指标方面,治疗组明显优于对照组(P<0.05)。结论:中药桂芍知母汤联合来氟米特治疗急性期类风湿关节炎可明显减少来氟米特副作用,提高治疗敏感性,中西医结合总体治疗疗效安全可靠、迅速并且稳定。Objective:To observe the clinical curative efficacy of classical guishao zhimu decoction combined with leflunomide in treatment of acute rheumatoid arthritis.Methods: 80 cases of actue rheumatoid arthritis according to the visiting sequence were randomly and equally divided into the treatment group and the control group.The control group were treated with leflunomide,20 mg a day, while the treatment group were given guishao zhimu decoction on the basis of the treatment of the control group.Two groups according to the condition of application of non-steroidal anti-inflammatory drugs ( diclofenac sodium dual release enteric- coated capsules,75 mg a day ) or low dose glucocorticoids 7.5 mg a day, Less than 4 weeks of treatment,12 weeks as a course of treatment.After treatment 6,12 weeks,observing and comparing the curative effect index of two groups.Results:The treatment group was better than the control group on the observation index ( P 〈 0.05 ) Conelusion:Guishao zhimu decoction combined with leflunomide in the treatment of patients with acute rheumatoid arthritis can significantly reduce the side effect of leflunomide,Improve the therapeutic sensitivity.The curative effec of Chinese-western medicine treatment was safe and reliable, fast and stable
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.74